TBI9DIM1332-Global Biotherapeutics Cell Line Market Research Report 2019-2023

  • TBI880120
  • June 19, 2019
  • Global
  • 152 pages
  • 9Dimen Research
                                              The rapid growth of the global geriatric population fuel the rising prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cancer, and multiple sclerosisare are the key factors driving the growth for the Biotherapeutics Cell Line market, according to research, the global Biotherapeutics Cell Line market is expected to reach USD 81million by 2020.

Geographically, North America is leading the market in owing to their advanced medical technology and earliest research, and the presence of a large pool of leading biopharmaceutical companies has stimulated the biotherapeutics cell line development activities in this region, leading to remarkable growth in the market, according to research, the North America is likely to increase to USD $33 million by the end of 2020.

Region followed by Europe, the second largest market for the forecast period, which is expected to have significant growth over 2016-2020. Asia Pacific, region where is undergoing the aging population situation that stimulants the unmet medical needs and the increasing investments by major pharma companies is projected to amplify the development of biotherapeutics cell line in this region.

On the basis of cell type, ingle cell cloning and transfection and selection are the two main processes for biotherapeutics cell line development. Single cell cloning led the market with a share of 96% in 2014. The growing adoption of instruments such as FACS and ClonePix has added significantly to the growth of single cell cloning in the recent times.

Global top Biotherapeutics Cell Line research giants are Becton Dickinson and Co. and Beckman Coulter. Boehringer Ingelheim Pharma GmbH & Co KG., CMC Biologics, Catalent Inc., Lonza Group Ltd., ProBioGen AG, Partec, SAFC, Sony Biotechnology Inc., Selexis SA, and Thermo Fisher Scientific Inc., among others.

Biotherapeutics Cell Line Report by Material, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

The report firstly introduced the Biotherapeutics Cell Line basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. 

Table of Contents

Part I Biotherapeutics Cell Line Industry Overview

Chapter One Biotherapeutics Cell Line Industry Overview
1.1 Biotherapeutics Cell Line Definition
1.2 Biotherapeutics Cell Line Classification Analysis
1.2.1 Biotherapeutics Cell Line Main Classification Analysis
1.2.2 Biotherapeutics Cell Line Main Classification Share Analysis
1.3 Biotherapeutics Cell Line Application Analysis
1.3.1 Biotherapeutics Cell Line Main Application Analysis
1.3.2 Biotherapeutics Cell Line Main Appl
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form

 

Related Reports